KMTS · Nasdaq · CIK 0001877184

KESTRA MEDICAL TECHNOLOGIES, LTD.

KESTRA MEDICAL TECHNOLOGIES, LTD.’s most recent SEC filing in our snapshot is a Form 144 filed on Oct 27, 2026. In fiscal 2026 (year ended Apr 30, 2026) it reported revenue of $95.1M and net income of -$131.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 44 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$95.1M
Net income, FY2026
-$131.6M
Form 4 filings on record, past 12 months
44

Company overview

Legal name (as filed)
KESTRA MEDICAL TECHNOLOGIES, LTD.
Ticker
KMTS
SEC Central Index Key (CIK)
0001877184
Business address
KIRKLAND, WA
State or country of incorporation
Bermuda
Fiscal year ends
April 30
SEC filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Position in SEC ticker list
#2094 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from KESTRA MEDICAL TECHNOLOGIES, LTD.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$27.8MFY2024$59.8MFY2025$95.1MFY2026
Net income
-$94.1MFY2024-$113.8MFY2025-$131.6MFY2026
KMTS annual results
ItemFY2024
ended Apr 30, 2024		FY2025
ended Apr 30, 2025		FY2026
ended Apr 30, 2026
Revenue$27.8M$59.8M$95.1M
Net income-$94.1M-$113.8M-$131.6M
Diluted EPS-$5.07-$5.13-$2.43
Total assets$45.9M$295.7M$358.5M
Cash and equivalents$8.2M$237.6M$99.7M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

KMTS latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Jul 14, 202610-KAnnual report· period Apr 30, 2026Document · Index
Sep 14, 202610-QQuarterly report· period Jul 31, 2026Document · Index
Sep 14, 20268-KResults of operations· period Sep 14, 2026Document · Index
Jul 28, 2026DEF 14ADefinitive proxy statement· period Sep 9, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about KESTRA MEDICAL TECHNOLOGIES, LTD., by form type:

144 ×204 ×168-K ×210-Q ×1SCHEDULE 13G/A ×1
KMTS recent filings
FiledFormWhat it isOriginal
Oct 27, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 27, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 22, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 21, 2026Document · Index
Oct 22, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 20, 2026Document · Index
Oct 21, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 20, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 1, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Sep 30, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 23, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 21, 2026Document · Index
Sep 21, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 14, 202610-QQuarterly report· period Jul 31, 2026Document · Index
Sep 14, 20268-KResults of operations· period Sep 14, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 9, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 9, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 10, 20268-KShareholder vote results· period Sep 9, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 8, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 8, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 8, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 8, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 17, 2026Document · Index
Aug 17, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026Document · Index
Aug 7, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 3, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 3, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 3, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 3, 2026144Notice of proposed sale of securitiesDocument · Index

Insider filing activity

44 Form 4 filings appear in KESTRA MEDICAL TECHNOLOGIES, LTD.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Washington

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001877184 and XBRL company facts. KESTRA MEDICAL TECHNOLOGIES, LTD. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.